Paper39587458
Sarcopenia's Role in Neoadjuvant Chemotherapy Outcomes for Locally Advanced Breast Cancer: A Retrospective Analysis.
Karaca M and 8 others. Med Sci Monit, 2024. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. Sarcopenia's Role in Neoadjuvant Chemotherapy Outcomes for Locally Advanced Breast Cancer: A Retrospective Analysis. Papers, record 39587458. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39587458
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Sarcopenia's Role in Neoadjuvant Chemotherapy Outcomes for Locally Advanced Breast Cancer: A Retrospective Analysis.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Sarcopenia | Major topic |
| Neoadjuvant Therapy | Major topic |
| Breast Neoplasms | Major topic |
| Humans | |
| Female | |
| Retrospective Studies | |
| Middle Aged | |
| Aged | |
| Adult | |
| Treatment Outcome | |
| Kaplan-Meier Estimate | |
| Psoas Muscles | |
| Chemotherapy, Adjuvant | |
| Neoplasm Staging |
Source PubMed
References36
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 23908848 | Lifestyle and sarcopenia-etiology, prevention, and treatment. | Rambam Maimonides Med J | 2012 | https://conductscience.org/library/papers/23908848 | PubMed |
| 2 | 30139644 | The impact of preoperative sarcopenia, defined based on psoas muscle area, on long-term outcomes of heart valve surgery. | J Thorac Cardiovasc Surg | 2019 | https://conductscience.org/library/papers/30139644 | PubMed |
| 3 | 33046106 | Health-related quality of life in breast cancer patients: review of reviews from 2008 to 2018. | Health Qual Life Outcomes | 2020 | https://conductscience.org/library/papers/33046106 | PubMed |
| 4 | 33294497 | Comparison between body composition parameters and response to neoadjuvant chemotherapy by using pre-treatment PET CT in locally advanced breast cancer. | Eur J Radiol Open | 2020 | https://conductscience.org/library/papers/33294497 | PubMed |
| 5 | 28734552 | Prevalence and predictive value of pre-therapeutic sarcopenia in cancer patients: A systematic review. | Clin Nutr | 2018 | https://conductscience.org/library/papers/28734552 | PubMed |
| 6 | 24189893 | Impact of sarcopenia on the prognosis and treatment toxicities in patients diagnosed with cancer. | Curr Opin Support Palliat Care | 2013 | https://conductscience.org/library/papers/24189893 | PubMed |
| 7 | 14659147 | A new histological grading system to assess response of breast cancers to primary chemotherapy: prognostic significance and survival. | Breast | 2003 | https://conductscience.org/library/papers/14659147 | PubMed |
| 8 | 18757321 | Relationship between obesity and pathologic response to neoadjuvant chemotherapy among women with operable breast cancer. | J Clin Oncol | 2008 | https://conductscience.org/library/papers/18757321 | PubMed |
| 9 | 22903527 | The relationship between body composition and response to neoadjuvant chemotherapy in women with operable breast cancer. | Oncologist | 2012 | https://conductscience.org/library/papers/22903527 | PubMed |
| 10 | 33557032 | The Prognostic Impact of Body Composition for Locally Advanced Breast Cancer Patients Who Received Neoadjuvant Chemotherapy. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/33557032 | PubMed |
| 11 | 34780924 | Impact of Sarcopenia on Outcomes of Minimally Invasive Cardiac Surgery. | Semin Thorac Cardiovasc Surg | 2023 | https://conductscience.org/library/papers/34780924 | PubMed |
| 12 | 26343952 | Computed tomography-defined muscle and fat wasting are associated with cancer clinical outcomes. | Semin Cell Dev Biol | 2016 | https://conductscience.org/library/papers/26343952 | PubMed |
| 13 | 19351764 | Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment. | Clin Cancer Res | 2009 | https://conductscience.org/library/papers/19351764 | PubMed |
| 14 | 30312372 | Sarcopenia: revised European consensus on definition and diagnosis. | Age Ageing | 2019 | https://conductscience.org/library/papers/30312372 | PubMed |
| 15 | 25925237 | Impact Total Psoas Volume on Short- and Long-Term Outcomes in Patients Undergoing Curative Resection for Pancreatic Adenocarcinoma: a New Tool to Assess Sarcopenia. | J Gastrointest Surg | 2015 | https://conductscience.org/library/papers/25925237 | PubMed |
| 16 | 37354335 | Hematologic toxicities, sarcopenia, and body composition change in breast cancer patients undergoing neoadjuvant chemotherapy. | Support Care Cancer | 2023 | https://conductscience.org/library/papers/37354335 | PubMed |
| 17 | 22144825 | Cancer cachexia. | J Oral Maxillofac Pathol | 2011 | https://conductscience.org/library/papers/22144825 | PubMed |
| 18 | 35933845 | Rethinking breast cancer follow-up based on individual risk and recurrence management. | Cancer Treat Rev | 2022 | https://conductscience.org/library/papers/35933845 | PubMed |
| 19 | 36536266 | Muscle mass loss in breast cancer patients of reproductive age (≤ 45 years) undergoing neoadjuvant chemotherapy. | Radiol Med | 2023 | https://conductscience.org/library/papers/36536266 | PubMed |
| 20 | 27489287 | Skeletal Muscle Measures as Predictors of Toxicity, Hospitalization, and Survival in Patients with Metastatic Breast Cancer Receiving Taxane-Based Chemotherapy. | Clin Cancer Res | 2017 | https://conductscience.org/library/papers/27489287 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42941441 | Pretreatment Body Composition Parameters and HALP Score in Relation to Pathological Complete Response in HER2-Positive Breast Cancer Receiving Neoadjuvant Systemic Therapy. | J Clin Med | 2026 | https://conductscience.org/library/papers/42941441 | PubMed |
| 42779147 | Predictive Value of CT-Derived Skeletal Muscle Metrics for Pathologic Complete Response in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy. | Eur J Breast Health | 2026 | https://conductscience.org/library/papers/42779147 | PubMed |
| 42581091 | Associations of body composition with neoadjuvant chemotherapy response, toxicity, and prognosis in breast cancer: a scoping review. | Cancer Chemother Pharmacol | 2026 | https://conductscience.org/library/papers/42581091 | PubMed |
| 42495721 | The relationship between sarcopenia and breast cancer: mechanistic pathways and clinical relevance. | Front Cell Dev Biol | 2026 | https://conductscience.org/library/papers/42495721 | PubMed |
| 42200373 | Change in skeletal muscle mass during systemic cancer treatment: a systematic review and meta-analysis. | Acta Oncol | 2026 | https://conductscience.org/library/papers/42200373 | PubMed |
| 41010899 | Low Skeletal Muscle Index as a Predictor of Pathological Complete Response in HER-2 Positive and Triple-Negative Breast Cancer. | Medicina (Kaunas) | 2025 | https://conductscience.org/library/papers/41010899 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39587458
GET https://conductscience.org/api/papers/v1/39587458/references?page=2